Automated description from the Alliance of Genome Resources (Release 7.0.0)
Predicted to enable CCR2 chemokine receptor binding activity; heparin binding activity; and lipopolysaccharide binding activity. Predicted to be involved in innate immune response. Predicted to act upstream of or within defense response to bacterium. Predicted to be located in membrane; microvesicle; and nucleus. Orthologous to human DEFB106A (defensin beta 106A) and DEFB106B (defensin beta 106B).